Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Research Grants

Desmoid Tumor Research Foundation

The Desmoid Tumor Research Foundation (DTRF) is dedicated to facilitating and funding research that leads to a cure for desmoid tumors. Desmoid tumors (also known as aggressive fibromatosis, desmoid fibromatosis, and desmoid-type fibromatosis) are rare, locally invasive, soft tissue tumors that form in the connective tissues of the body. We fund research that uses cutting-edge science and creative clinical applications, in addition to novel approaches addressing potential leads based on prior research.

DTRF is particularly interested in innovative and translational research projects and will consider applications across the spectrum of research from basic science to clinical trials and correlative studies. The grant amount may be up to $65,000 USD per year for a grant term of one to three years. Investigators applying for pilot funding may apply for funding up to $30,000 USD per year for a grant term of one year. This is limited to those who may not have an established line of research in the desmoid tumor research space or who have an innovative pilot project idea to collect preliminary data in advance of future grant applications

Specialties

Cancer

Oncology

Eligibility Requirements

Applicants must have an MD, PhD, MD/PhD, or equivalent degree, hold an academic rank of Assistant Professor or higher, and be sponsored by an Exempt Organization as defined by Section 501(c)(3) of the Internal Revenue Code (the “Sponsoring Institution”) or the equivalent in a foreign jurisdiction. Individuals with an established track record in desmoid tumors, beta-catenin, sarcomas, or related fields are encouraged to apply. Early Stage Investigators are also strongly encouraged to apply and will be given special consideration in the scoring process. An Early Stage Investigator is defined as a Principal Investigator (PI) who has completed their terminal research degree or end of post-graduate clinical training, whichever is later, within the past seven (7) years and who has not previously competed successfully as a PI for a DTRF Research Grant.

Sponsor Details

Sponsor Institute/Organizations: Desmoid Tumor Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity